USE OF MELATONIN IN THE TREATMENT OF SLEEP DISORDERS IN PATIENTS WITH PARKINSON’S DISEASE

Cover Page

Cite item

Full Text

Abstract

The paper analyzes the causes and clinical manifestations of sleep and awakening disorders in Parkinson’s disease, describes clinical cases with dyssomnia at the early and extensive stages of the disease and the efficiency of using melatonin to normalize circadian rhythm.

About the authors

E. N. Gubanova

Russian Medical Academy of Postgraduate Education, Ministry of Health of Russia

Center of Extrapyramidal Diseases, Ministry of Health of Russia

Department of Neurology Russian Federation

N. V. Fedorova

Russian Medical Academy of Postgraduate Education, Ministry of Health of Russia

Center of Extrapyramidal Diseases, Ministry of Health of Russia

Author for correspondence.
Email: natalia.fedorova@list.ru
Department of Neurology Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2013 Gubanova E.N., Fedorova N.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-36931 от  21.07.2009.